Table of Content

1 Active Pharma Ingredient Market Overview
1.1 Active Pharma Ingredient Product Scope
1.2 Active Pharma Ingredient Segment by Type
1.2.1 Global Active Pharma Ingredient Sales by Type (2016 & 2021 & 2027)
1.2.2 Innovative Active Pharmaceutical Ingredients
1.2.3 Generic Active Pharmaceutical Ingredients
1.3 Active Pharma Ingredient Segment by Application
1.3.1 Global Active Pharma Ingredient Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Oncology
1.3.3 Cardiovascular Disease
1.3.4 Diabetes
1.3.5 Central Nervous System and Neurological Disorders
1.3.6 Endocrinology
1.3.7 Other Therapeutic Applications
1.4 Active Pharma Ingredient Market Estimates and Forecasts (2016-2027)
1.4.1 Global Active Pharma Ingredient Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Active Pharma Ingredient Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Active Pharma Ingredient Price Trends (2016-2027)

2 Active Pharma Ingredient Estimates and Forecasts by Region
2.1 Global Active Pharma Ingredient Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Active Pharma Ingredient Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Active Pharma Ingredient Sales Market Share by Region (2016-2021)
2.2.2 Global Active Pharma Ingredient Revenue Market Share by Region (2016-2021)
2.3 Global Active Pharma Ingredient Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Active Pharma Ingredient Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Active Pharma Ingredient Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Active Pharma Ingredient Estimates and Projections (2016-2027)
2.4.2 Europe Active Pharma Ingredient Estimates and Projections (2016-2027)
2.4.3 China Active Pharma Ingredient Estimates and Projections (2016-2027)
2.4.4 Japan Active Pharma Ingredient Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Active Pharma Ingredient Estimates and Projections (2016-2027)
2.4.6 India Active Pharma Ingredient Estimates and Projections (2016-2027)

3 Global Active Pharma Ingredient Competition Landscape by Players
3.1 Global Top Active Pharma Ingredient Players by Sales (2016-2021)
3.2 Global Top Active Pharma Ingredient Players by Revenue (2016-2021)
3.3 Global Active Pharma Ingredient Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Active Pharma Ingredient as of 2020)
3.4 Global Active Pharma Ingredient Average Price by Company (2016-2021)
3.5 Manufacturers Active Pharma Ingredient Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Active Pharma Ingredient Market Size by Type
4.1 Global Active Pharma Ingredient Historic Market Review by Type (2016-2021)
4.1.1 Global Active Pharma Ingredient Sales Market Share by Type (2016-2021)
4.1.2 Global Active Pharma Ingredient Revenue Market Share by Type (2016-2021)
4.1.3 Global Active Pharma Ingredient Price by Type (2016-2021)
4.2 Global Active Pharma Ingredient Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Active Pharma Ingredient Sales Forecast by Type (2022-2027)
4.2.2 Global Active Pharma Ingredient Revenue Forecast by Type (2022-2027)
4.2.3 Global Active Pharma Ingredient Price Forecast by Type (2022-2027)

5 Global Active Pharma Ingredient Market Size by Application
5.1 Global Active Pharma Ingredient Historic Market Review by Application (2016-2021)
5.1.1 Global Active Pharma Ingredient Sales Market Share by Application (2016-2021)
5.1.2 Global Active Pharma Ingredient Revenue Market Share by Application (2016-2021)
5.1.3 Global Active Pharma Ingredient Price by Application (2016-2021)
5.2 Global Active Pharma Ingredient Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Active Pharma Ingredient Sales Forecast by Application (2022-2027)
5.2.2 Global Active Pharma Ingredient Revenue Forecast by Application (2022-2027)
5.2.3 Global Active Pharma Ingredient Price Forecast by Application (2022-2027)

6 North America Active Pharma Ingredient Market Facts & Figures
6.1 North America Active Pharma Ingredient Sales by Company
6.1.1 North America Active Pharma Ingredient Sales by Company (2016-2021)
6.1.2 North America Active Pharma Ingredient Revenue by Company (2016-2021)
6.2 North America Active Pharma Ingredient Sales Breakdown by Type
6.2.1 North America Active Pharma Ingredient Sales Breakdown by Type (2016-2021)
6.2.2 North America Active Pharma Ingredient Sales Breakdown by Type (2022-2027)
6.3 North America Active Pharma Ingredient Sales Breakdown by Application
6.3.1 North America Active Pharma Ingredient Sales Breakdown by Application (2016-2021)
6.3.2 North America Active Pharma Ingredient Sales Breakdown by Application (2022-2027)

7 Europe Active Pharma Ingredient Market Facts & Figures
7.1 Europe Active Pharma Ingredient Sales by Company
7.1.1 Europe Active Pharma Ingredient Sales by Company (2016-2021)
7.1.2 Europe Active Pharma Ingredient Revenue by Company (2016-2021)
7.2 Europe Active Pharma Ingredient Sales Breakdown by Type
7.2.1 Europe Active Pharma Ingredient Sales Breakdown by Type (2016-2021)
7.2.2 Europe Active Pharma Ingredient Sales Breakdown by Type (2022-2027)
7.3 Europe Active Pharma Ingredient Sales Breakdown by Application
7.3.1 Europe 145 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 145 Sales Breakdown by Application (2022-2027)

8 China Active Pharma Ingredient Market Facts & Figures
8.1 China Active Pharma Ingredient Sales by Company
8.1.1 China Active Pharma Ingredient Sales by Company (2016-2021)
8.1.2 China Active Pharma Ingredient Revenue by Company (2016-2021)
8.2 China Active Pharma Ingredient Sales Breakdown by Type
8.2.1 China Active Pharma Ingredient Sales Breakdown by Type (2016-2021)
8.2.2 China Active Pharma Ingredient Sales Breakdown by Type (2022-2027)
8.3 China Active Pharma Ingredient Sales Breakdown by Application
8.3.1 China 174 Sales Breakdown by Application (2016-2021)
8.3.2 China 174 Sales Breakdown by Application (2022-2027)

9 Japan Active Pharma Ingredient Market Facts & Figures
9.1 Japan Active Pharma Ingredient Sales by Company
9.1.1 Japan Active Pharma Ingredient Sales by Company (2016-2021)
9.1.2 Japan Active Pharma Ingredient Revenue by Company (2016-2021)
9.2 Japan Active Pharma Ingredient Sales Breakdown by Type
9.2.1 Japan Active Pharma Ingredient Sales Breakdown by Type (2016-2021)
9.2.2 Japan Active Pharma Ingredient Sales Breakdown by Type (2022-2027)
9.3 Japan Active Pharma Ingredient Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Active Pharma Ingredient Market Facts & Figures
10.1 Southeast Asia Active Pharma Ingredient Sales by Company
10.1.1 Southeast Asia Active Pharma Ingredient Sales by Company (2016-2021)
10.1.2 Southeast Asia Active Pharma Ingredient Revenue by Company (2016-2021)
10.2 Southeast Asia Active Pharma Ingredient Sales Breakdown by Type
10.2.1 Southeast Asia Active Pharma Ingredient Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Active Pharma Ingredient Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Active Pharma Ingredient Sales Breakdown by Application
10.3.1 Southeast Asia K Pcs Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Pcs Sales Breakdown by Application (2022-2027)

11 India Active Pharma Ingredient Market Facts & Figures
11.1 India Active Pharma Ingredient Sales by Company
11.1.1 India Active Pharma Ingredient Sales by Company (2016-2021)
11.1.2 India Active Pharma Ingredient Revenue by Company (2016-2021)
11.2 India Active Pharma Ingredient Sales Breakdown by Type
11.2.1 India Active Pharma Ingredient Sales Breakdown by Type (2016-2021)
11.2.2 India Active Pharma Ingredient Sales Breakdown by Type (2022-2027)
11.3 India Active Pharma Ingredient Sales Breakdown by Application
11.3.1 India Active Pharma Ingredient Sales Breakdown by Application (2016-2021)
11.3.2 India Active Pharma Ingredient Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Active Pharma Ingredient Business
12.1 Teva
12.1.1 Teva Corporation Information
12.1.2 Teva Business Overview
12.1.3 Teva Active Pharma Ingredient Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Teva Active Pharma Ingredient Products Offered
12.1.5 Teva Recent Development
12.2 Novartis
12.2.1 Novartis Corporation Information
12.2.2 Novartis Business Overview
12.2.3 Novartis Active Pharma Ingredient Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Novartis Active Pharma Ingredient Products Offered
12.2.5 Novartis Recent Development
12.3 Pfizer
12.3.1 Pfizer Corporation Information
12.3.2 Pfizer Business Overview
12.3.3 Pfizer Active Pharma Ingredient Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Pfizer Active Pharma Ingredient Products Offered
12.3.5 Pfizer Recent Development
12.4 Johnson & Johnson
12.4.1 Johnson & Johnson Corporation Information
12.4.2 Johnson & Johnson Business Overview
12.4.3 Johnson & Johnson Active Pharma Ingredient Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Johnson & Johnson Active Pharma Ingredient Products Offered
12.4.5 Johnson & Johnson Recent Development
12.5 Mylan
12.5.1 Mylan Corporation Information
12.5.2 Mylan Business Overview
12.5.3 Mylan Active Pharma Ingredient Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Mylan Active Pharma Ingredient Products Offered
12.5.5 Mylan Recent Development
12.6 North China Pharmaceutical Group
12.6.1 North China Pharmaceutical Group Corporation Information
12.6.2 North China Pharmaceutical Group Business Overview
12.6.3 North China Pharmaceutical Group Active Pharma Ingredient Sales, Revenue and Gross Margin (2016-2021)
12.6.4 North China Pharmaceutical Group Active Pharma Ingredient Products Offered
12.6.5 North China Pharmaceutical Group Recent Development
12.7 Dr. Reddy’s Laboratories
12.7.1 Dr. Reddy’s Laboratories Corporation Information
12.7.2 Dr. Reddy’s Laboratories Business Overview
12.7.3 Dr. Reddy’s Laboratories Active Pharma Ingredient Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Dr. Reddy’s Laboratories Active Pharma Ingredient Products Offered
12.7.5 Dr. Reddy’s Laboratories Recent Development
12.8 Roche
12.8.1 Roche Corporation Information
12.8.2 Roche Business Overview
12.8.3 Roche Active Pharma Ingredient Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Roche Active Pharma Ingredient Products Offered
12.8.5 Roche Recent Development
12.9 Aurobindo pharma
12.9.1 Aurobindo pharma Corporation Information
12.9.2 Aurobindo pharma Business Overview
12.9.3 Aurobindo pharma Active Pharma Ingredient Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Aurobindo pharma Active Pharma Ingredient Products Offered
12.9.5 Aurobindo pharma Recent Development
12.10 Sun Pharmaceutical Industries
12.10.1 Sun Pharmaceutical Industries Corporation Information
12.10.2 Sun Pharmaceutical Industries Business Overview
12.10.3 Sun Pharmaceutical Industries Active Pharma Ingredient Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Sun Pharmaceutical Industries Active Pharma Ingredient Products Offered
12.10.5 Sun Pharmaceutical Industries Recent Development
12.11 Boehringer Ingelheim GmbH
12.11.1 Boehringer Ingelheim GmbH Corporation Information
12.11.2 Boehringer Ingelheim GmbH Business Overview
12.11.3 Boehringer Ingelheim GmbH Active Pharma Ingredient Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Boehringer Ingelheim GmbH Active Pharma Ingredient Products Offered
12.11.5 Boehringer Ingelheim GmbH Recent Development
12.12 Bayer
12.12.1 Bayer Corporation Information
12.12.2 Bayer Business Overview
12.12.3 Bayer Active Pharma Ingredient Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Bayer Active Pharma Ingredient Products Offered
12.12.5 Bayer Recent Development
12.13 BASF
12.13.1 BASF Corporation Information
12.13.2 BASF Business Overview
12.13.3 BASF Active Pharma Ingredient Sales, Revenue and Gross Margin (2016-2021)
12.13.4 BASF Active Pharma Ingredient Products Offered
12.13.5 BASF Recent Development
12.14 DSM
12.14.1 DSM Corporation Information
12.14.2 DSM Business Overview
12.14.3 DSM Active Pharma Ingredient Sales, Revenue and Gross Margin (2016-2021)
12.14.4 DSM Active Pharma Ingredient Products Offered
12.14.5 DSM Recent Development
12.15 Zhejiang Medicine
12.15.1 Zhejiang Medicine Corporation Information
12.15.2 Zhejiang Medicine Business Overview
12.15.3 Zhejiang Medicine Active Pharma Ingredient Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Zhejiang Medicine Active Pharma Ingredient Products Offered
12.15.5 Zhejiang Medicine Recent Development
12.16 Biocon
12.16.1 Biocon Corporation Information
12.16.2 Biocon Business Overview
12.16.3 Biocon Active Pharma Ingredient Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Biocon Active Pharma Ingredient Products Offered
12.16.5 Biocon Recent Development
12.17 Johnson Matthey
12.17.1 Johnson Matthey Corporation Information
12.17.2 Johnson Matthey Business Overview
12.17.3 Johnson Matthey Active Pharma Ingredient Sales, Revenue and Gross Margin (2016-2021)
12.17.4 Johnson Matthey Active Pharma Ingredient Products Offered
12.17.5 Johnson Matthey Recent Development
12.18 Hisun Pharmacy
12.18.1 Hisun Pharmacy Corporation Information
12.18.2 Hisun Pharmacy Business Overview
12.18.3 Hisun Pharmacy Active Pharma Ingredient Sales, Revenue and Gross Margin (2016-2021)
12.18.4 Hisun Pharmacy Active Pharma Ingredient Products Offered
12.18.5 Hisun Pharmacy Recent Development
12.19 Cambrex
12.19.1 Cambrex Corporation Information
12.19.2 Cambrex Business Overview
12.19.3 Cambrex Active Pharma Ingredient Sales, Revenue and Gross Margin (2016-2021)
12.19.4 Cambrex Active Pharma Ingredient Products Offered
12.19.5 Cambrex Recent Development
12.20 Shandong Xinhua Pharmaceutical
12.20.1 Shandong Xinhua Pharmaceutical Corporation Information
12.20.2 Shandong Xinhua Pharmaceutical Business Overview
12.20.3 Shandong Xinhua Pharmaceutical Active Pharma Ingredient Sales, Revenue and Gross Margin (2016-2021)
12.20.4 Shandong Xinhua Pharmaceutical Active Pharma Ingredient Products Offered
12.20.5 Shandong Xinhua Pharmaceutical Recent Development
12.21 Lonza group
12.21.1 Lonza group Corporation Information
12.21.2 Lonza group Business Overview
12.21.3 Lonza group Active Pharma Ingredient Sales, Revenue and Gross Margin (2016-2021)
12.21.4 Lonza group Active Pharma Ingredient Products Offered
12.21.5 Lonza group Recent Development
12.22 Huahai Pharmaceutical
12.22.1 Huahai Pharmaceutical Corporation Information
12.22.2 Huahai Pharmaceutical Business Overview
12.22.3 Huahai Pharmaceutical Active Pharma Ingredient Sales, Revenue and Gross Margin (2016-2021)
12.22.4 Huahai Pharmaceutical Active Pharma Ingredient Products Offered
12.22.5 Huahai Pharmaceutical Recent Development
12.23 Haerbin Pharmaceutical Group
12.23.1 Haerbin Pharmaceutical Group Corporation Information
12.23.2 Haerbin Pharmaceutical Group Business Overview
12.23.3 Haerbin Pharmaceutical Group Active Pharma Ingredient Sales, Revenue and Gross Margin (2016-2021)
12.23.4 Haerbin Pharmaceutical Group Active Pharma Ingredient Products Offered
12.23.5 Haerbin Pharmaceutical Group Recent Development
12.24 Cipla
12.24.1 Cipla Corporation Information
12.24.2 Cipla Business Overview
12.24.3 Cipla Active Pharma Ingredient Sales, Revenue and Gross Margin (2016-2021)
12.24.4 Cipla Active Pharma Ingredient Products Offered
12.24.5 Cipla Recent Development
12.25 Tian Yao
12.25.1 Tian Yao Corporation Information
12.25.2 Tian Yao Business Overview
12.25.3 Tian Yao Active Pharma Ingredient Sales, Revenue and Gross Margin (2016-2021)
12.25.4 Tian Yao Active Pharma Ingredient Products Offered
12.25.5 Tian Yao Recent Development
12.26 Lupin
12.26.1 Lupin Corporation Information
12.26.2 Lupin Business Overview
12.26.3 Lupin Active Pharma Ingredient Sales, Revenue and Gross Margin (2016-2021)
12.26.4 Lupin Active Pharma Ingredient Products Offered
12.26.5 Lupin Recent Development
12.27 North East Pharmaceutical
12.27.1 North East Pharmaceutical Corporation Information
12.27.2 North East Pharmaceutical Business Overview
12.27.3 North East Pharmaceutical Active Pharma Ingredient Sales, Revenue and Gross Margin (2016-2021)
12.27.4 North East Pharmaceutical Active Pharma Ingredient Products Offered
12.27.5 North East Pharmaceutical Recent Development
12.28 Albemarle
12.28.1 Albemarle Corporation Information
12.28.2 Albemarle Business Overview
12.28.3 Albemarle Active Pharma Ingredient Sales, Revenue and Gross Margin (2016-2021)
12.28.4 Albemarle Active Pharma Ingredient Products Offered
12.28.5 Albemarle Recent Development
12.29 Shandong Lukang Pharmaceutical
12.29.1 Shandong Lukang Pharmaceutical Corporation Information
12.29.2 Shandong Lukang Pharmaceutical Business Overview
12.29.3 Shandong Lukang Pharmaceutical Active Pharma Ingredient Sales, Revenue and Gross Margin (2016-2021)
12.29.4 Shandong Lukang Pharmaceutical Active Pharma Ingredient Products Offered
12.29.5 Shandong Lukang Pharmaceutical Recent Development
12.30 Jiangsu Hengrui Medicine
12.30.1 Jiangsu Hengrui Medicine Corporation Information
12.30.2 Jiangsu Hengrui Medicine Business Overview
12.30.3 Jiangsu Hengrui Medicine Active Pharma Ingredient Sales, Revenue and Gross Margin (2016-2021)
12.30.4 Jiangsu Hengrui Medicine Active Pharma Ingredient Products Offered
12.30.5 Jiangsu Hengrui Medicine Recent Development

13 Active Pharma Ingredient Manufacturing Cost Analysis
13.1 Active Pharma Ingredient Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Active Pharma Ingredient
13.4 Active Pharma Ingredient Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Active Pharma Ingredient Distributors List
14.3 Active Pharma Ingredient Customers

15 Market Dynamics
15.1 Active Pharma Ingredient Market Trends
15.2 Active Pharma Ingredient Drivers
15.3 Active Pharma Ingredient Market Challenges
15.4 Active Pharma Ingredient Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Active Pharma Ingredient Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Active Pharma Ingredient Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Active Pharma Ingredient Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Active Pharma Ingredient Sales (K Pcs) by Region (2016-2021)
Table 5. Global Active Pharma Ingredient Sales Market Share by Region (2016-2021)
Table 6. Global Active Pharma Ingredient Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Active Pharma Ingredient Revenue Share by Region (2016-2021)
Table 8. Global Active Pharma Ingredient Sales (K Pcs) Forecast by Region (2022-2027)
Table 9. Global Active Pharma Ingredient Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Active Pharma Ingredient Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Active Pharma Ingredient Revenue Share Forecast by Region (2022-2027)
Table 12. Global Active Pharma Ingredient Sales (K Pcs) of Key Companies (2016-2021)
Table 13. Global Active Pharma Ingredient Sales Share by Company (2016-2021)
Table 14. Global Active Pharma Ingredient Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Active Pharma Ingredient Revenue Share by Company (2016-2021)
Table 16. Global Active Pharma Ingredient by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Active Pharma Ingredient as of 2020)
Table 17. Global Active Pharma Ingredient Average Price (USD/Pcs) of Key Company (2016-2021)
Table 18. Manufacturers Active Pharma Ingredient Manufacturing Sites and Area Served
Table 19. Manufacturers Active Pharma Ingredient Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Active Pharma Ingredient Sales (K Pcs) by Type (2016-2021)
Table 22. Global Active Pharma Ingredient Sales Share by Type (2016-2021)
Table 23. Global Active Pharma Ingredient Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Active Pharma Ingredient Price (USD/Pcs) by Type (2016-2021)
Table 25. Global Active Pharma Ingredient Sales Share by Type (2022-2027)
Table 26. Global Active Pharma Ingredient Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Active Pharma Ingredient Revenue Share by Type (2022-2027)
Table 28. Global Active Pharma Ingredient Price (USD/Pcs) by Type (2022-2027)
Table 29. Global Active Pharma Ingredient Sales (K Pcs) by Application (2016-2021)
Table 30. Global Active Pharma Ingredient Sales Share by Application (2016-2021)
Table 31. Global Active Pharma Ingredient Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Active Pharma Ingredient Price (USD/Pcs) by Application (2016-2021)
Table 33. Global Active Pharma Ingredient Sales (K Pcs) by Application (2022-2027)
Table 34. Global Active Pharma Ingredient Sales Share by Application (2022-2027)
Table 35. Global Active Pharma Ingredient Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Active Pharma Ingredient Revenue Share by Application (2022-2027)
Table 37. Global Active Pharma Ingredient Price (USD/Pcs) by Application (2022-2027)
Table 38. North America Active Pharma Ingredient Sales (K Pcs) by Company (2016-2021)
Table 39. North America Active Pharma Ingredient Sales Market Share by Company (2016-2021)
Table 40. North America Active Pharma Ingredient Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Active Pharma Ingredient Revenue Market Share by Company (2016-2021)
Table 42. North America Active Pharma Ingredient Sales by Type (2016-2021) & (K Pcs)
Table 43. North America Active Pharma Ingredient Sales Market Share by Type (2016-2021)
Table 44. North America Active Pharma Ingredient Sales by Type (2022-2027) & (K Pcs)
Table 45. North America Active Pharma Ingredient Sales Market Share by Type (2022-2027)
Table 46. North America Active Pharma Ingredient Sales by Application (2016-2021) & (K Pcs)
Table 47. North America Active Pharma Ingredient Sales Market Share by Application (2016-2021)
Table 48. North America Active Pharma Ingredient Sales by Application (2022-2027) & (K Pcs)
Table 49. North America Active Pharma Ingredient Sales Market Share by Application (2022-2027)
Table 50. Europe Active Pharma Ingredient Sales (K Pcs) by Company (2016-2021)
Table 51. Europe Active Pharma Ingredient Sales Market Share by Company (2016-2021)
Table 52. Europe Active Pharma Ingredient Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Active Pharma Ingredient Revenue Market Share by Company (2016-2021)
Table 54. Europe Active Pharma Ingredient Sales by Type (2016-2021) & (K Pcs)
Table 55. Europe Active Pharma Ingredient Sales Market Share by Type (2016-2021)
Table 56. Europe Active Pharma Ingredient Sales by Type (2022-2027) & (K Pcs)
Table 57. Europe Active Pharma Ingredient Sales Market Share by Type (2022-2027)
Table 58. Europe Active Pharma Ingredient Sales by Application (2016-2021) & (K Pcs)
Table 59. Europe Active Pharma Ingredient Sales Market Share by Application (2016-2021)
Table 60. Europe Active Pharma Ingredient Sales by Application (2022-2027) & (K Pcs)
Table 61. Europe Active Pharma Ingredient Sales Market Share by Application (2022-2027)
Table 62. China Active Pharma Ingredient Sales (K Pcs) by Company (2016-2021)
Table 63. China Active Pharma Ingredient Sales Market Share by Company (2016-2021)
Table 64. China Active Pharma Ingredient Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Active Pharma Ingredient Revenue Market Share by Company (2016-2021)
Table 66. China Active Pharma Ingredient Sales by Type (2016-2021) & (K Pcs)
Table 67. China Active Pharma Ingredient Sales Market Share by Type (2016-2021)
Table 68. China Active Pharma Ingredient Sales by Type (2022-2027) & (K Pcs)
Table 69. China Active Pharma Ingredient Sales Market Share by Type (2022-2027)
Table 70. China Active Pharma Ingredient Sales by Application (2016-2021) & (K Pcs)
Table 71. China Active Pharma Ingredient Sales Market Share by Application (2016-2021)
Table 72. China Active Pharma Ingredient Sales by Application (2022-2027) & (K Pcs)
Table 73. China Active Pharma Ingredient Sales Market Share by Application (2022-2027)
Table 74. Japan Active Pharma Ingredient Sales (K Pcs) by Company (2016-2021)
Table 75. Japan Active Pharma Ingredient Sales Market Share by Company (2016-2021)
Table 76. Japan Active Pharma Ingredient Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Active Pharma Ingredient Revenue Market Share by Company (2016-2021)
Table 78. Japan Active Pharma Ingredient Sales by Type (2016-2021) & (K Pcs)
Table 79. Japan Active Pharma Ingredient Sales Market Share by Type (2016-2021)
Table 80. Japan Active Pharma Ingredient Sales by Type (2022-2027) & (K Pcs)
Table 81. Japan Active Pharma Ingredient Sales Market Share by Type (2022-2027)
Table 82. Japan Active Pharma Ingredient Sales by Application (2016-2021) & (K Pcs)
Table 83. Japan Active Pharma Ingredient Sales Market Share by Application (2016-2021)
Table 84. Japan Active Pharma Ingredient Sales by Application (2022-2027) & (K Pcs)
Table 85. Japan Active Pharma Ingredient Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Active Pharma Ingredient Sales (K Pcs) by Company (2016-2021)
Table 87. Southeast Asia Active Pharma Ingredient Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Active Pharma Ingredient Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Active Pharma Ingredient Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Active Pharma Ingredient Sales by Type (2016-2021) & (K Pcs)
Table 91. Southeast Asia Active Pharma Ingredient Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Active Pharma Ingredient Sales by Type (2022-2027) & (K Pcs)
Table 93. Southeast Asia Active Pharma Ingredient Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Active Pharma Ingredient Sales by Application (2016-2021) & (K Pcs)
Table 95. Southeast Asia Active Pharma Ingredient Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Active Pharma Ingredient Sales by Application (2022-2027) & (K Pcs)
Table 97. Southeast Asia Active Pharma Ingredient Sales Market Share by Application (2022-2027)
Table 98. India Active Pharma Ingredient Sales (K Pcs) by Company (2016-2021)
Table 99. India Active Pharma Ingredient Sales Market Share by Company (2016-2021)
Table 100. India Active Pharma Ingredient Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Active Pharma Ingredient Revenue Market Share by Company (2016-2021)
Table 102. India Active Pharma Ingredient Sales by Type (2016-2021) & (K Pcs)
Table 103. India Active Pharma Ingredient Sales Market Share by Type (2016-2021)
Table 104. India Active Pharma Ingredient Sales by Type (2022-2027) & (K Pcs)
Table 105. India Active Pharma Ingredient Sales Market Share by Type (2022-2027)
Table 106. India Active Pharma Ingredient Sales by Application (2016-2021) & (K Pcs)
Table 107. India Active Pharma Ingredient Sales Market Share by Application (2016-2021)
Table 108. India Active Pharma Ingredient Sales by Application (2022-2027) & (K Pcs)
Table 109. India Active Pharma Ingredient Sales Market Share by Application (2022-2027)
Table 110. Teva Corporation Information
Table 111. Teva Description and Business Overview
Table 112. Teva Active Pharma Ingredient Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 113. Teva Active Pharma Ingredient Product
Table 114. Teva Recent Development
Table 115. Novartis Corporation Information
Table 116. Novartis Description and Business Overview
Table 117. Novartis Active Pharma Ingredient Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 118. Novartis Active Pharma Ingredient Product
Table 119. Novartis Recent Development
Table 120. Pfizer Corporation Information
Table 121. Pfizer Description and Business Overview
Table 122. Pfizer Active Pharma Ingredient Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 123. Pfizer Active Pharma Ingredient Product
Table 124. Pfizer Recent Development
Table 125. Johnson & Johnson Corporation Information
Table 126. Johnson & Johnson Description and Business Overview
Table 127. Johnson & Johnson Active Pharma Ingredient Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 128. Johnson & Johnson Active Pharma Ingredient Product
Table 129. Johnson & Johnson Recent Development
Table 130. Mylan Corporation Information
Table 131. Mylan Description and Business Overview
Table 132. Mylan Active Pharma Ingredient Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 133. Mylan Active Pharma Ingredient Product
Table 134. Mylan Recent Development
Table 135. North China Pharmaceutical Group Corporation Information
Table 136. North China Pharmaceutical Group Description and Business Overview
Table 137. North China Pharmaceutical Group Active Pharma Ingredient Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 138. North China Pharmaceutical Group Active Pharma Ingredient Product
Table 139. North China Pharmaceutical Group Recent Development
Table 140. Dr. Reddy’s Laboratories Corporation Information
Table 141. Dr. Reddy’s Laboratories Description and Business Overview
Table 142. Dr. Reddy’s Laboratories Active Pharma Ingredient Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 143. Dr. Reddy’s Laboratories Active Pharma Ingredient Product
Table 144. Dr. Reddy’s Laboratories Recent Development
Table 145. Roche Corporation Information
Table 146. Roche Active Pharma Ingredient Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 147. Roche Description and Business Overview
Table 148. Roche Active Pharma Ingredient Product
Table 149. Roche Recent Development
Table 150. Aurobindo pharma Corporation Information
Table 151. Aurobindo pharma Active Pharma Ingredient Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 152. Aurobindo pharma Description and Business Overview
Table 153. Aurobindo pharma Active Pharma Ingredient Product
Table 154. Aurobindo pharma Recent Development
Table 155. Sun Pharmaceutical Industries Corporation Information
Table 156. Sun Pharmaceutical Industries Description and Business Overview
Table 157. Sun Pharmaceutical Industries Active Pharma Ingredient Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 158. Sun Pharmaceutical Industries Active Pharma Ingredient Product
Table 159. Sun Pharmaceutical Industries Recent Development
Table 160. Boehringer Ingelheim GmbH Corporation Information
Table 161. Boehringer Ingelheim GmbH Description and Business Overview
Table 162. Boehringer Ingelheim GmbH Active Pharma Ingredient Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 163. Boehringer Ingelheim GmbH Active Pharma Ingredient Product
Table 164. Boehringer Ingelheim GmbH Recent Development
Table 165. Bayer Corporation Information
Table 166. Bayer Description and Business Overview
Table 167. Bayer Active Pharma Ingredient Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 168. Bayer Active Pharma Ingredient Product
Table 169. Bayer Recent Development
Table 170. BASF Corporation Information
Table 171. BASF Description and Business Overview
Table 172. BASF Active Pharma Ingredient Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 173. BASF Active Pharma Ingredient Product
Table 174. BASF Recent Development
Table 175. DSM Corporation Information
Table 176. DSM Description and Business Overview
Table 177. DSM Active Pharma Ingredient Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 178. DSM Active Pharma Ingredient Product
Table 179. DSM Recent Development
Table 180. Zhejiang Medicine Corporation Information
Table 181. Zhejiang Medicine Description and Business Overview
Table 182. Zhejiang Medicine Active Pharma Ingredient Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 183. Zhejiang Medicine Active Pharma Ingredient Product
Table 184. Zhejiang Medicine Recent Development
Table 185. Biocon Corporation Information
Table 186. Biocon Description and Business Overview
Table 187. Biocon Active Pharma Ingredient Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 188. Biocon Active Pharma Ingredient Product
Table 189. Biocon Recent Development
Table 190. Johnson Matthey Corporation Information
Table 191. Johnson Matthey Description and Business Overview
Table 192. Johnson Matthey Active Pharma Ingredient Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 193. Johnson Matthey Active Pharma Ingredient Product
Table 194. Johnson Matthey Recent Development
Table 195. Hisun Pharmacy Corporation Information
Table 196. Hisun Pharmacy Description and Business Overview
Table 197. Hisun Pharmacy Active Pharma Ingredient Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 198. Hisun Pharmacy Active Pharma Ingredient Product
Table 199. Hisun Pharmacy Recent Development
Table 200. Cambrex Corporation Information
Table 201. Cambrex Description and Business Overview
Table 202. Cambrex Active Pharma Ingredient Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 203. Cambrex Active Pharma Ingredient Product
Table 204. Cambrex Recent Development
Table 205. Shandong Xinhua Pharmaceutical Corporation Information
Table 206. Shandong Xinhua Pharmaceutical Description and Business Overview
Table 207. Shandong Xinhua Pharmaceutical Active Pharma Ingredient Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 208. Shandong Xinhua Pharmaceutical Active Pharma Ingredient Product
Table 209. Shandong Xinhua Pharmaceutical Recent Development
Table 210. Lonza group Corporation Information
Table 211. Lonza group Description and Business Overview
Table 212. Lonza group Active Pharma Ingredient Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 213. Lonza group Active Pharma Ingredient Product
Table 214. Lonza group Recent Development
Table 215. Huahai Pharmaceutical Corporation Information
Table 216. Huahai Pharmaceutical Description and Business Overview
Table 217. Huahai Pharmaceutical Active Pharma Ingredient Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 218. Huahai Pharmaceutical Active Pharma Ingredient Product
Table 219. Huahai Pharmaceutical Recent Development
Table 220. Haerbin Pharmaceutical Group Corporation Information
Table 221. Haerbin Pharmaceutical Group Description and Business Overview
Table 222. Haerbin Pharmaceutical Group Active Pharma Ingredient Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 223. Haerbin Pharmaceutical Group Active Pharma Ingredient Product
Table 224. Haerbin Pharmaceutical Group Recent Development
Table 225. Cipla Corporation Information
Table 226. Cipla Description and Business Overview
Table 227. Cipla Active Pharma Ingredient Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 228. Cipla Active Pharma Ingredient Product
Table 229. Cipla Recent Development
Table 230. Tian Yao Corporation Information
Table 231. Tian Yao Description and Business Overview
Table 232. Tian Yao Active Pharma Ingredient Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 233. Tian Yao Active Pharma Ingredient Product
Table 234. Tian Yao Recent Development
Table 235. Lupin Corporation Information
Table 236. Lupin Description and Business Overview
Table 237. Lupin Active Pharma Ingredient Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 238. Lupin Active Pharma Ingredient Product
Table 239. Lupin Recent Development
Table 240. North East Pharmaceutical Corporation Information
Table 241. North East Pharmaceutical Description and Business Overview
Table 242. North East Pharmaceutical Active Pharma Ingredient Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 243. North East Pharmaceutical Active Pharma Ingredient Product
Table 244. North East Pharmaceutical Recent Development
Table 245. Albemarle Corporation Information
Table 246. Albemarle Description and Business Overview
Table 247. Albemarle Active Pharma Ingredient Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 248. Albemarle Active Pharma Ingredient Product
Table 249. Albemarle Recent Development
Table 250. Shandong Lukang Pharmaceutical Corporation Information
Table 251. Shandong Lukang Pharmaceutical Description and Business Overview
Table 252. Shandong Lukang Pharmaceutical Active Pharma Ingredient Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 253. Shandong Lukang Pharmaceutical Active Pharma Ingredient Product
Table 254. Shandong Lukang Pharmaceutical Recent Development
Table 255. Jiangsu Hengrui Medicine Corporation Information
Table 256. Jiangsu Hengrui Medicine Description and Business Overview
Table 257. Jiangsu Hengrui Medicine Active Pharma Ingredient Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 258. Jiangsu Hengrui Medicine Active Pharma Ingredient Product
Table 259. Jiangsu Hengrui Medicine Recent Development
Table 260. Production Base and Market Concentration Rate of Raw Material
Table 261. Key Suppliers of Raw Materials
Table 262. Active Pharma Ingredient Distributors List
Table 263. Active Pharma Ingredient Customers List
Table 264. Active Pharma Ingredient Market Trends
Table 265. Active Pharma Ingredient Market Drivers
Table 266. Active Pharma Ingredient Market Challenges
Table 267. Active Pharma Ingredient Market Restraints
Table 268. Research Programs/Design for This Report
Table 269. Key Data Information from Secondary Sources
Table 270. Key Data Information from Primary Sources
List of Figures
Figure 1. Active Pharma Ingredient Product Picture
Figure 2. Global Active Pharma Ingredient Sales Market Share by Type in 2021 & 2027
Figure 3. Innovative Active Pharmaceutical Ingredients Product Picture
Figure 4. Generic Active Pharmaceutical Ingredients Product Picture
Figure 5. Global Active Pharma Ingredient Sales Market Share by Application in 2021 & 2027
Figure 6. Oncology Examples
Figure 7. Cardiovascular Disease Examples
Figure 8. Diabetes Examples
Figure 9. Central Nervous System and Neurological Disorders Examples
Figure 10. Endocrinology Examples
Figure 11. Other Therapeutic Applications Examples
Figure 12. Global Active Pharma Ingredient Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Active Pharma Ingredient Sales Growth Rate (2016-2027) & (US$ Million)
Figure 14. Global Active Pharma Ingredient Sales (K Pcs) Growth Rate (2016-2027)
Figure 15. Global Active Pharma Ingredient Price Trends Growth Rate (2016-2027) (USD/Pcs)
Figure 16. Global Active Pharma Ingredient Revenue Market Share by Region: 2016 VS 2021
Figure 17. Global Active Pharma Ingredient Revenue Market Share by Region: 2021 VS 2027
Figure 18. North America Active Pharma Ingredient Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. North America Active Pharma Ingredient Sales (K Pcs) Growth Rate (2016-2027)
Figure 20. Europe Active Pharma Ingredient Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. Europe Active Pharma Ingredient Sales (Million USD) Growth Rate (2016-2027)
Figure 22. China Active Pharma Ingredient Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. China Active Pharma Ingredient Sales (Million USD) and Growth Rate (2016-2027)
Figure 24. Japan Active Pharma Ingredient Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. Japan Active Pharma Ingredient Sales (Million USD) Growth Rate (2016-2027)
Figure 26. Southeast Asia Active Pharma Ingredient Revenue (Million USD) Growth Rate (2016-2027)
Figure 27. Southeast Asia Active Pharma Ingredient Sales (Million USD) Growth Rate (2016-2027)
Figure 28. India Active Pharma Ingredient Revenue (Million USD) Growth Rate (2016-2027)
Figure 29. India Active Pharma Ingredient Sales (Million USD) Growth Rate (2016-2027)
Figure 30. Global 5 Largest Active Pharma Ingredient Players Market Share by Revenue in Active Pharma Ingredient: 2016 & 2020
Figure 31. Active Pharma Ingredient Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 32. Global Active Pharma Ingredient Revenue Share by Type (2016-2021)
Figure 33. Global Active Pharma Ingredient Revenue Growth Rate by Type in 2016 & 2020
Figure 34. Global Active Pharma Ingredient Revenue Share by Application (2016-2021)
Figure 35. Global Active Pharma Ingredient Revenue Growth Rate by Application in 2016 & 2020
Figure 36. North America Active Pharma Ingredient Sales Market Share by Type in 2020
Figure 37. North America Active Pharma Ingredient Sales Market Share by Application in 2020
Figure 38. Europe Active Pharma Ingredient Sales Market Share by Type in 2020
Figure 39. Europe Active Pharma Ingredient Sales Market Share by Application in 2020
Figure 40. China Active Pharma Ingredient Sales Market Share by Type in 2020
Figure 41. China Active Pharma Ingredient Sales Market Share by Application in 2020
Figure 42. Japan Active Pharma Ingredient Sales Market Share by Type in 2020
Figure 43. Japan Active Pharma Ingredient Sales Market Share by Application in 2020
Figure 44. Southeast Asia Active Pharma Ingredient Sales Market Share by Type in 2020
Figure 45. Southeast Asia Active Pharma Ingredient Sales Market Share by Application in 2020
Figure 46. India Active Pharma Ingredient Sales Market Share by Type in 2020
Figure 47. India Active Pharma Ingredient Sales Market Share by Application in 2020
Figure 48. Key Raw Materials Price Trend
Figure 49. Manufacturing Cost Structure of Active Pharma Ingredient
Figure 50. Manufacturing Process Analysis of Active Pharma Ingredient
Figure 51. Active Pharma Ingredient Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed